No results for ‘’
Entero Healthcare Solutions Ltd
₹1089.40
(1.46%)
Mon, 22 Jun 2026, 09:25 am
Distribution Services
Medical Distributors
24.5KEntero Healthcare Solutions Price to Cash Flow Ratio
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 91.09 | 52.22 |
| Price to book ratio | 0 | 0 | 0 | 2.62 | 2.87 |
| Price to sales ratio | 0 | 0 | 0 | 0.91 | 0.97 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 | 3011Cr | 4921Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 26.92 | 28.59 |
| Debt to equity ratio | 0.42 | 0.63 | 0.74 | 0.21 | 0.22 |
| Return on equity % | 0 | -5.72 | -2 | 3.50 | 5.64 |
Entero Healthcare Solutions Ltd Price to Cash Flow Ratio
The Entero Healthcare Solutions Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Entero Healthcare Solutions Ltd's valuation, profitability, and overall financial performance. Tracking the Entero Healthcare Solutions Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Entero Healthcare Solutions Ltd (NSE: ENTERO, BSE: 544122) is currently trading at ₹1089.40, with a market capitalization of ₹4751.53Cr. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Entero Healthcare Solutions Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Entero Healthcare Solutions Ltd Price to Cash Flow Ratio Current Value
The current Entero Healthcare Solutions Ltd Price to Cash Flow Ratio stands at 0.
The Entero Healthcare Solutions Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Entero Healthcare Solutions Ltd Price to Cash Flow Ratio Historical Trend
The Entero Healthcare Solutions Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0
The decline in Entero Healthcare Solutions Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Entero Healthcare Solutions Ltd Price to Cash Flow Ratio Indicates for Investors
The Entero Healthcare Solutions Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Entero Healthcare Solutions Ltd Price to Cash Flow Ratio Analysis Summary
The Entero Healthcare Solutions Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Entero Healthcare Solutions Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Entero Healthcare Solutions Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.